Jennifer Akridge v. ALFA Mutual Insurance Company

1 F.4th 1271
CourtCourt of Appeals for the Eleventh Circuit
DecidedJune 21, 2021
Docket19-10827
StatusPublished
Cited by23 cases

This text of 1 F.4th 1271 (Jennifer Akridge v. ALFA Mutual Insurance Company) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jennifer Akridge v. ALFA Mutual Insurance Company, 1 F.4th 1271 (11th Cir. 2021).

Opinion

USCA11 Case: 19-10827 Date Filed: 06/21/2021 Page: 1 of 14

[PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT ________________________

No. 19-10827 ________________________

D.C. Docket No. 2:17-cv-00372-GMB

JENNIFER AKRIDGE,

Plaintiff - Appellant,

versus

ALFA MUTUAL INSURANCE COMPANY,

Defendant - Appellee.

________________________

Appeal from the United States District Court for the Middle District of Alabama ________________________

(June 21, 2021)

Before WILSON, GRANT, and TJOFLAT, Circuit Judges.

WILSON, Circuit Judge: USCA11 Case: 19-10827 Date Filed: 06/21/2021 Page: 2 of 14

This appeal concerns the impermissible curtailment of a civil plaintiff’s

access to full discovery. Plaintiff-Appellant Jennifer Akridge filed a complaint

against her former employer, Defendant-Appellee Alfa Mutual Insurance Company

(Alfa), alleging disability discrimination in violation of the Americans with

Disabilities Act (ADA), 42 U.S.C. § 12112. Akridge alleged that, although Alfa

claims she was terminated because of automation of some of her job

responsibilities, she was actually terminated because of the high costs to Alfa in

treating her multiple sclerosis (MS). The district court granted summary judgment

to Alfa, finding that Akridge presented insufficient evidence to create a genuine

issue of material fact about whether there was an intent to discriminate. This

appeal followed. Because we find that Akridge was denied full discovery, we

reverse the grant of summary judgment.

I.

Jennifer Akridge was hired as an agency clerk in 1989, beginning what

would become a 27-year career at Alfa. Two years later, Akridge was promoted to

the Auto Underwriting Department, where she would spend the remainder of her

time at Alfa. In 1993, after her promotion, Akridge was diagnosed with MS.

Akridge was initially hospitalized due to complications arising from her MS. After

being released from the hospital, she filed for short term disability and was away

2 USCA11 Case: 19-10827 Date Filed: 06/21/2021 Page: 3 of 14

from work for ten weeks. Consequently, some Alfa executives and members of the

Human Resources Department knew of Akridge’s diagnosis.

Akridge’s diagnosis altered many aspects of her life: her MS causes her to

suffer from migraine headaches and prevents her from sitting for long periods of

time as her legs will become numb or restless; the numbness and associated

mobility issues resulted in Akridge’s reliance on a walker upon her return to work;

and, to manage her condition, she now has to take many expensive prescribed

medications for the rest of her life as MS has no cure.1 However, one aspect of

Akridge’s life remained constant: her work performance.

Despite her diagnosis, Akridge not only continued to perform her necessary

job duties, but consistently received positive performance reviews. In fact, two

years after her diagnosis, Akridge was selected out of almost 1,000 employees as

Alfa’s “Employee of the Year.” Akridge continued to receive excellent work

evaluations and was promoted to a management-level position in the Underwriting

Department in 1998. Multiple Alfa employees testified to Akridge’s work ethic,

her positive work evaluations, and the quality of her work. Tony Bohannon, a co-

1 Akridge affied that her medications cost around $10,000 per month. Due to the high expense, BlueCross BlueShield had to get annual approval from Alfa to continue covering the medication. Akridge also stated that, in the two-year period prior to her termination, employees were verbally cautioned by Alfa about rising healthcare expenses and were reminded that these expenses affect employees’ healthcare premiums. 3 USCA11 Case: 19-10827 Date Filed: 06/21/2021 Page: 4 of 14

worker of Akridge’s for over 22 years, swore in an affidavit to Akridge’s

“outstanding” work quality, noting “[w]hat was especially amazing [was] that she

received an ‘E’ (Exceeds expectations) [evaluation] continually for as many as 15–

17 years.” These positive work reviews continued until Akridge was fired on

December 2, 2016. The quality of her work never declined: even in her last

evaluation before her termination, Akridge’s then-supervisor Linda Pelt noted that

Akridge went “the extra mile to help customers and the people in the field” and

“did a great job with all the projects she was assigned.” According to Bohannon,

“[i]t was rare to see an employee terminated, especially with an ‘E’ evaluation.”

However, these positive performance reviews did not stop Alfa from terminating

Akridge.

Akridge filed the present suit against Alfa in 2017. In her amended

complaint, Akridge alleged that Alfa violated the ADA by subjecting her to

disparate treatment based on her disability. 2 According to Akridge, Alfa

discriminated against her by terminating her to avoid paying the expensive health

insurance costs related to her MS treatment. Alfa answered and denied liability.

The parties then consented to have a magistrate judge enter a final judgment in

2 Akridge also alleged that Alfa failed to provide her with a reasonable accommodation for her disability, in violation of the ADA. The magistrate judge granted Alfa summary judgment on this claim, and Akridge does not challenge that ruling on appeal. 4 USCA11 Case: 19-10827 Date Filed: 06/21/2021 Page: 5 of 14

their case. The magistrate judge, in turn, entered a scheduling order directing the

parties to complete discovery.

From the outset of discovery, Akridge sought to depose ten Alfa employees,

including Scott Forrest, the then-Executive Vice President of Human Resources.

Following a series of attempts to depose Forrest, Akridge filed two motions to

compel his deposition, which Alfa opposed. The magistrate judge denied both

motions.

In May 2018, Akridge again moved to compel Forrest’s deposition, asserting

that his testimony was “relevant and necessary.” Again, Alfa opposed Akridge’s

motion, noting that Forrest did not have any relevant information about Akridge’s

termination. In an affidavit, Forrest denied consulting with the individuals who did

have relevant and necessary information—Underwriting Department supervisors

Tommy Coshatt, Beth Chancey, and Robert Plaster—before Akridge’s termination.

He further denied having any involvement with the decision. According to Alfa’s

response to interrogatories, only Coshatt, Chancey, and Plaster (collectively,

decisionmakers)3 “participated in any way, directly or indirectly, in the decision to

eliminate [Akridge’s] job.”

3 The district court and the parties used the term “decisionmakers” to refer to Coshatt, Chancey, and Plaster. We adopt the same term on appeal. 5 USCA11 Case: 19-10827 Date Filed: 06/21/2021 Page: 6 of 14

In addition to deposing the decisionmakers, Akridge twice deposed Alfa’s

corporate representative Susie White, a member of Alfa’s Human Resources

Department who reported to Forrest. White testified that no one at Alfa knew of

any employee’s medical costs and that Alfa did not maintain records on such costs.

White also testified that Coshatt and Chancey decided to eliminate Akridge’s

position because, after departmental restructuring, it was no longer necessary. In

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
1 F.4th 1271, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jennifer-akridge-v-alfa-mutual-insurance-company-ca11-2021.